Sarepta Therapeutics (SRPT) Q3 2025 Earnings

6AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-4.6
-2.44
-0.27
1.89

Details

Expected EPS
0.832292
Actual EPS
1.89
Surprise EPS
1.06
Surprise Percent
+127.08%

Description

Sarepta Therapeutics (SRPT) has reported earnings of 1.89 per share for Q3 2025.

1 Comments

inoyu

Great numbers on ELEVIDYS assuming it's all ambulatory patients.

0